XHKG1827
Market cap60mUSD
Jan 03, Last price
1.17HKD
1D
0.00%
1Q
6.36%
IPO
-74.57%
Name
Miricor Enterprises Holdings Ltd
Chart & Performance
Profile
Miricor Enterprises Holdings Limited, an investment holding company, provides medical aesthetic services in Hong Kong. It also offers a range of non-surgical medical aesthetic services, including energy-based and injection procedures. The company operates three medical aesthetic centers under the CosMax+ name. It also sells skin care products, such as cleansers, toners, serums, moisturizers, eye care products, ultraviolet protection products, and masks. Miricor Enterprises Holdings Limited was founded in 2009 and is headquartered in Causeway Bay, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 494,260 6.72% | 463,117 27.26% | 363,915 182.39% | |||||||
Cost of revenue | 359,840 | 313,789 | 219,938 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 134,420 | 149,328 | 143,977 | |||||||
NOPBT Margin | 27.20% | 32.24% | 39.56% | |||||||
Operating Taxes | 836 | (3,366) | 5,819 | |||||||
Tax Rate | 0.62% | 4.04% | ||||||||
NOPAT | 133,584 | 152,694 | 138,158 | |||||||
Net income | (12,616) -38.46% | (20,501) -180.77% | 25,382 -300.60% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 48,241 | 63,637 | 37,997 | |||||||
Long-term debt | 138,747 | 177,745 | 58,319 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 8,800 | 9,749 | 89,587 | |||||||
Net debt | 11,149 | 124,471 | (238,039) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 84,451 | 99,453 | 44,029 | |||||||
CAPEX | (26,215) | (26,781) | (111,638) | |||||||
Cash from investing activities | (59,000) | (37,840) | (97,510) | |||||||
Cash from financing activities | (55,586) | (21,924) | (28,735) | |||||||
FCF | 160,390 | 204,568 | (32,201) | |||||||
Balance | ||||||||||
Cash | 145,432 | 116,911 | 65,680 | |||||||
Long term investments | 30,407 | 268,675 | ||||||||
Excess cash | 151,126 | 93,755 | 316,159 | |||||||
Stockholders' equity | 70,055 | 233,384 | 274,442 | |||||||
Invested Capital | 175,257 | 191,566 | 30,154 | |||||||
ROIC | 72.83% | 137.74% | ||||||||
ROCE | 53.83% | 51.77% | 46.84% | |||||||
EV | ||||||||||
Common stock shares outstanding | 400,000 | 400,000 | 400,000 | |||||||
Price | 1.33 6.40% | 1.25 66.67% | ||||||||
Market cap | 532,000 6.40% | 500,000 66.67% | ||||||||
EV | 806,930 | 432,921 | ||||||||
EBITDA | 227,664 | 239,875 | 203,765 | |||||||
EV/EBITDA | 3.36 | 2.12 | ||||||||
Interest | 5,155 | 3,660 | 3,027 | |||||||
Interest/NOPBT | 3.83% | 2.45% | 2.10% |